Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$3.80 USD
-0.07 (-1.81%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.80 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/1/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 21.05% |
ABR | 2.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.94 |
Next Year | -1.84 |
EPS (TTM) | -1.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.80M | 0.80M | 2.63M | NA |
# of Estimates | 6 | 6 | 6 | NA |
High Estimate | 1.00M | 1.00M | 4.00M | NA |
Low Estimate | 0.50M | 0.50M | 1.50M | NA |
Year ago Sales | 58.98M | 0.93M | 63.53M | 2.63M |
Year over Year Growth Est. | -98.64% | -13.98% | -95.86% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.47 | -1.94 | -1.84 |
# of Estimates | 9 | 7 | 11 | 8 |
Most Recent Consensus | -0.46 | -0.47 | -1.90 | -1.50 |
High Estimate | -0.43 | -0.38 | -1.67 | -1.43 |
Low Estimate | -0.56 | -0.53 | -2.62 | -2.12 |
Year ago EPS | -0.19 | -0.54 | -1.64 | -1.94 |
Year over Year Growth Est. | -152.63% | 12.96% | -18.29% | 5.14% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 5 | 4 | 9 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.47 | -1.94 | -1.84 |
7 Days Ago | -0.48 | -0.47 | -1.94 | -1.84 |
30 Days Ago | -0.48 | -0.47 | -1.89 | -1.76 |
60 Days Ago | -0.57 | -0.55 | -2.16 | -1.80 |
90 Days Ago | -0.57 | -0.55 | -2.16 | -1.78 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.48 | -0.47 | -1.77 | -1.43 |
Zacks Consensus Estimate | -0.48 | -0.47 | -1.94 | -1.84 |
Earnings ESP | 0.00% | 0.00% | 8.64% | 22.18% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.46 | -0.54 | -0.19 | NA |
Estimate | -0.57 | -0.59 | -0.58 | -0.55 | NA |
Difference | 0.12 | 0.13 | 0.04 | 0.36 | 0.16 |
Surprise | 21.05% | 22.03% | 6.90% | 65.45% | 28.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more